Skip to main content

Table 3 Prevalence of dyslipidemia among women with precancerous lesions of the cervix attending the cervical cancer clinic at Uganda Cancer Institute, Mulago-Kampala, between Feb 2022 and April 2022

From: Dyslipidemia: prevalence and association with precancerous and cancerous lesions of the cervix; a pilot study

Variables

 

ASUS

LSIL

ASC-H

HSIL

TEST

P-value

N = 22

N = 65

N = 22

N = 27

HDL-c

HDL-c DYSLIPIDEMIA

6 (27%)

14 (22%)

7 (32%)

12 (44%)

Chi-square

0.05*

NORMAL HDL-c

16 (73%)

51 (78%)

15(68%)

15 (56%)

  

TG-c

NORMAL TRIG

18 (82%)

54 (83%)

17 (77%)

15(52%)

Fisher’s exact

 < 0.002*

TRIG DYSLIPIDEMIA

4 (18%)

11 (17%)

5(23%)

13 (48%)

  

LDL-c

NORMAL LDL-c

14 (64%)

45 (69%)

14 (64%)

18 (67%)

Chi-square

0.72

LDL-c DYSLIPIDEMIA

8 (36%)

20 (31%)

8 (36%)

9 (33%)

  

TC

NORMAL TCHOL

18 (82%)

49 (75%)

14 (64%)

17 (63%)

Fisher’s exact

0.036*

TCHOL DYSLIPIDEMIA

4 (18%)

16 (25%)

8 (36%)

10 (37%)

  
  1. ASC-H Atypical squamous cells cannot exclude HSIL, ASCUS Atypical squamous cells of undetermined significance, LSIL Low-grade squamous intraepithelial lesion, HSIL High-grade squamous intraepithelial lesion, NILM Negative for intraepithelial lesion/malignancy, LDLc Low-density lipoprotein, HDLc High-density lipoprotein, T.G.s Triglycerides; TC-total cholesterol
  2. *P-value ≤ 0.05
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X